Jivi 500 IU powder and solvent for solution for injection, Jivi 1000 IU powder and solvent for solution for injection
BAY 94-9027/21824
Phase 3 small_molecule active
Quick answer
Jivi 500 IU powder and solvent for solution for injection, Jivi 1000 IU powder and solvent for solution for injection for Severe hemophilia A (<1% FVIII:C) is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Severe hemophilia A (<1% FVIII:C)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active